LEADER 02416nam 22005654a 450 001 9910449998803321 005 20200520144314.0 010 $a1-280-17930-9 010 $a9786610179305 010 $a0-309-53188-8 035 $a(CKB)1000000000030390 035 $a(OCoLC)70773895 035 $a(CaPaEBR)ebrary10075708 035 $a(SSID)ssj0000138801 035 $a(PQKBManifestationID)11146758 035 $a(PQKBTitleCode)TC0000138801 035 $a(PQKBWorkID)10105365 035 $a(PQKB)10321335 035 $a(MiAaPQ)EBC3377874 035 $a(Au-PeEL)EBL3377874 035 $a(CaPaEBR)ebr10075708 035 $a(CaONFJC)MIL17930 035 $a(OCoLC)923273837 035 $a(EXLCZ)991000000000030390 100 $a20040922d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDietary supplements$b[electronic resource] $ea framework for evaluating safety /$fCommittee on the Framework for Evaluating the Safety of Dietary Supplements, Food and Nutrition Board, Board on Life Sciences 210 $aWashington, D.C. $cNational Academies Press$dc2005 215 $a1 online resource (526 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-309-09110-1 320 $aIncludes bibliographical references and index. 327 $aApproaches used by others and existing safety frameworks -- The framework -- Categories of scientific evidence--human information and data -- Categories of scientific evidence--animal data -- Categories of scientific evidence--information about related substances -- Categories of scientific evidence--in vitro data -- Interactions -- Vulnerable groups and prevalence of use -- Scientific principles for integrating and evaluating the available data -- Applying the framework: case studies using the prototype safety monographs -- Factors influencing use of the safety framework -- Findings and recommendations. 606 $aDietary supplements$xEvaluation 606 $aDietary supplements$xToxicology 608 $aElectronic books. 615 0$aDietary supplements$xEvaluation. 615 0$aDietary supplements$xToxicology. 676 $a613.2/8 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910449998803321 996 $aDietary supplements$91936033 997 $aUNINA